The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
Abstract
The survival experience of 39 patients receiving long-term regular hemodialysis in Seattle since 1960 was studied with particular reference to mortality and morbidity from arteriosclerotic cardiovascular complications. Mean age (± 1 S.D.) was 37.0 ± 9.5 years for the group at the start of dialysis. Mean duration of treatment was 6.5 years (range, one to 13). Overall mortality was 56.4 per cent at the end of the 13-year follow-up period, and 14 of 23 deaths could be attributed to arteriosclerotic complications: myocardial infarction was responsible for eight, strokes for three, and refractory congestive heart failure for three deaths. The incidence of these complications was many times higher than for normal and hypertensive groups of comparable age, and similar to rates found in Type 2 hyperlipoproteinemia. These results indicate that accelerated atherosclerosis is a major risk to long-term survivors on maintenance hemodialysis. (N Engl J Med 290:697–701, 1974)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
KANNEL, W. B., DAWBER, T. R., KAGAN, A., REVOTSKIE, N., & STOKES, J. (1961) · Annals of Internal Medicine · doi:10.7326/0003-4819-55-1-33 · Cited by 1,837
Friedberg, C. K. (1966) · Biblioteca Digital (Real Academia Nacional de Medicina) · Cited by 1,393
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 623
Hypertriglyceridemia: A Metabolic Consequence of Chronic Renal Failure
Bagdade, J. D., Porte, D., & Bierman, E. L. (1968) · New England Journal of Medicine · doi:10.1056/nejm196807252790403 · Cited by 382
Cited by
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., Jungers, P., & Descamps-Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 1,999
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
Stenvinkel, P., Heimbürger, O., Paultre, F., Diczfalusy, U., Wang, T., Berglund, L., & Jogestrand, T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00422.x · Cited by 1,778
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., & Wanner, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00273.x · Cited by 1,531
Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients
Blacher, J., Asmar, R., Djane, S., London, G. M., & Safar, M. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1111 · Cited by 1,493
“70‐90 285 74 ( 26 ) 0.82 (0.56‐1.20) 0.69 (0.43‐1.11)”
InfluentialK/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition
Don, B. R., & Kaysen, G. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17603.x · Cited by 1,410
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Arterial stiffening and vascular calcifications in end‐stage renal disease
Guérin, A. P., London, G. M., Marchais, S. J., & Metivier, F. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.7.1014 · Cited by 1,003
Craddock, P. R., Fehr, J., Dalmasso, A. P., Brighan, K. L., & Jacob, H. S. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108710 · Cited by 991
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 932
Witko-Sarsat, V., Friedlander, M., Khoa, T. N., Capeillère-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J.-M., Jungers, P., Drüeke, T., & Descamps-Latscha, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2524 · Cited by 878
Braun, J., Oldendorf, M., Moshage, W., Heidler, R., Zeitler, E., & Luft, F. C. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90363-7 · Cited by 794
Impact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
Cardiovascular and noncardiovascular mortality among patients starting dialysis
de Jager, D. J. (2009) · JAMA · doi:10.1001/jama.2009.1488 · Cited by 755
Survival as an index of adequacy of dialysis
Charra, B., Calemard, E., Ruffet, M., Chazot, C., Terrat, J.-C., Vanel, T., & Laurent, G. (1992) · Kidney International · doi:10.1038/ki.1992.191 · Cited by 756
Self-citationAssociation of serum albumin and mortality risk
Goldwasser, P., & Feldman, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00015-2 · Cited by 716
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
Schwarz, U., Buzello, M., Ritz, E., Stein, G., Raabe, G., Wiest, G., Mall, G., & Amann, K. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.2.218 · Cited by 628
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., & Lameire, N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh813 · Cited by 613
Longenecker, J. C., Coresh, J., Powe, N. R., Levey, A. S., Fink, N. E., Martin, A., & Klag, M. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019641.41496.1e · Cited by 594
Cardiovascular disease and chronic renal disease: A new paradigm
Sarnak, M. J., & Levey, A. S. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70239-3 · Cited by 586
Aortic pulse wave velocity index and mortality in end-stage renal disease
Blacher, J., Safar, M. E., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00932.x · Cited by 532
The severe cardiorenal syndrome: ‘Guyton revisited’
Bongartz, L. G., Cramer, M. J., Doevendans, P. A., Joles, J. A., & Braam, B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi020 · Cited by 460
Diabetes Mellitus, Aortic Stiffness, and Cardiovascular Mortality in End-Stage Renal Disease
SHOJI, T., EMOTO, M., SHINOHARA, K., KAKIYA, R., TSUJIMOTO, Y., KISHIMOTO, H., ISHIMURA, E., TABATA, T., & NISHIZAWA, Y. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102117 · Cited by 450
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Ortiz, A., Covic, A., Fliser, D., Fouque, D., Goldsmith, D., Kanbay, M., Mallamaci, F., Massy, Z. A., Rossignol, P., Vanholder, R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60384-6 · Cited by 435
Elevated risk of stroke among patients with end-stage renal disease
Seliger, S. L., Gillen, D. L., Longstreth, W. T., Kestenbaum, B., & Stehman-Breen, C. O. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00101.x · Cited by 427
Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy
Stenvinkel, P., & Alvestrand, A. (2002) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2002.00083.x · Cited by 425
London, G. M., Guérin, A. P., Verbeke, F. H., Pannier, B., Boutouyrie, P., Marchais, S. J., & Mëtivier, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060573 · Cited by 414
Arici, M., & Walls, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002407.x · Cited by 398
Arterial stiffness and pulse pressure in CKD and ESRD
Briet, M., Boutouyrie, P., Laurent, S., & London, G. M. (2012) · Kidney International · doi:10.1038/ki.2012.131 · Cited by 392
Aortic and large artery compliance in end-stage renal failure
London, G. M., Marchais, S. J., Safar, M. E., Genest, A. F., Guerin, A. P., Metivier, F., Chedid, K., & London, A. M. (1990) · Kidney International · doi:10.1038/ki.1990.19 · Cited by 380
Shinohara, K., Shoji, T., Emoto, M., Tahara, H., Koyama, H., Ishimura, E., Miki, T., Tabata, T., & Nishizawa, Y. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019900.87535.43 · Cited by 377
KIELSTEIN, J. T., BÖGER, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., KOCH, K. M., & FRÖLICH, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 361
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
Fliser, D., Pacini, G., Engelleiter, R., Kautzky-Willer, A., Prager, R., Franek, E., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00898.x · Cited by 359
Lipoprotein Metabolism and Renal Failure
Attman, P.-O., Samuelsson, O., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 355
Atherosclerosis and arteriosclerosis in chronic renal failure
London, G. M., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.233 · Cited by 354
Cardiac arrest and sudden death in dialysis units
Karnik, J. A., Young, B. S., Lew, N. L., Herget, M., Dubinsky, C., Lazarus, J. M., & Chertow, G. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00806.x · Cited by 351
A survey of 246 suggested coronary risk factors
Hopkins, P. N., & Williams, R. R. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90122-2 · Cited by 351
Meier-Kriesche, H.-U., Schold, J. D., Srinivas, T. R., Reed, A., & Kaplan, B. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00573.x · Cited by 344
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease
Briet, M., Bozec, E., Laurent, S., Fassot, C., London, G. M., Jacquot, C., Froissart, M., Houillier, P., & Boutouyrie, P. (2006) · Kidney International · doi:10.1038/sj.ki.5000047 · Cited by 341
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease
Wang, M.-C., Tsai, W.-C., Chen, J.-Y., & Huang, J.-J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.11.011 · Cited by 336
Robinson, K., Gupta, A., Dennis, V., Arheart, K., Chaudhary, D., Green, R., Vigo, P., Mayer, E. L., Selhub, J., Kutner, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2743 · Cited by 334
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 332
Effect of parathyroid hormone on rat heart cells.
Bogin, E., Massry, S. G., & Harary, I. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110137 · Cited by 332
Qunibi, W., Moustafa, M., Muenz, L. R., He, D. Y., Kessler, P. D., Diaz-Buxo, J. A., & Budoff, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.298 · Cited by 311
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia
Kawagishi, T., Nishizawa, Y., Konishi, T., Kawasaki, K., Emoto, M., Shoji, T., Tabata, T., Inoue, T., & Morii, H. (1995) · Kidney International · doi:10.1038/ki.1995.356 · Cited by 311
London, G. M. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16023.x · Cited by 307
Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
Valdivielso, J. M., Rodríguez-Puyol, D., Pascual, J., Barrios, C., Bermúdez-López, M., Sánchez-Niño, M. D., Pérez-Fernández, M., & Ortiz, A. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312705 · Cited by 305
Park, C. W., Oh, Y. S., Shin, Y. S., Kim, C.-M., Kim, Y.-S., Kim, S. Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70260-x · Cited by 305
Myocardial infarction in the familial forms of hypertriglyceridemia
Brunzell, J. D., Schrott, H. G., Motulsky, A. G., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90089-5 · Cited by 303
The heart and vascular system in dialysis
Wanner, C., Amann, K., & Shoji, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30508-6 · Cited by 303
Arterial calcification and pathology in uremic patients undergoing dialysis
Ibels, L. S., Alfrey, A. C., Huffer, W. E., Craswell, P. W., Anderson, J. T., & Weil, R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91118-5 · Cited by 297
Left Ventricular Hypertrophy in the Renal Patient
MIDDLETON, R. J., PARFREY, P. S., & FOLEY, R. N. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251079 · Cited by 294
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients
Seliger, S. L., Weiss, N. S., Gillen, D. L., Kestenbaum, B., Ball, A., Sherrard, D. J., & Stehman-Breen, C. O. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00109.x · Cited by 294
Self-citationNON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients
Herzog, C. A., Mangrum, J. M., & Passman, R. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00455.x · Cited by 290
Lipid abnormalities in renal disease
Appel, G. (1991) · Kidney International · doi:10.1038/ki.1991.22 · Cited by 286
Ohtake, T., Kobayashi, S., Moriya, H., Negishi, K., Okamoto, K., Maesato, K., & Saito, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090765 · Cited by 283
Cardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
Ma, K. W., Greene, E. L., & Raij, L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80827-4 · Cited by 269
Role of Free Radicals in Aging and Disease
HARMAN, D. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb27444.x · Cited by 262
Pathophysiological mechanisms of vascular calcification in end-stage renal disease
Davies, M. R., & Hruska, K. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002472.x · Cited by 259
Coronary heart disease: the zinc/copper hypothesis
Klevay, L. (1975) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/28.7.764 · Cited by 258
Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia
London, G. M., Marchais, S. J., Guérin, A. P., & Métivier, F. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000168336.67499.c0 · Cited by 258
Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension.
Converse, R. L., Jacobsen, T. N., Jost, C. M., Toto, R. D., Grayburn, P. A., Obregon, T. M., Fouad-Tarazi, F., & Victor, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116037 · Cited by 256
RAINE, A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90293-0 · Cited by 256
The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
Buzello, M., Törnig, J., Faulhaber, J., Ehmke, H., Ritz, E., & Amann, K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045048.71975.fc · Cited by 167
Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
Briasoulis, A., & Bakris, G. L. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0340-4 · Cited by 152
The iron hypothesis of atherosclerosis and its clinical impact
Yuan, X., & Li, W. (2003) · Annals of Medicine · doi:10.1080/07853890310016342 · Cited by 93
Farkouh, M. E., Sidhu, M. S., Brooks, M. M., Vlachos, H., Boden, W. E., Frye, R. L., Hartigan, P., Siami, F. S., Bittner, V. A., Chaitman, B. R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.044 · Cited by 58
The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD)
Goldsmith, D. J. A., Massy, Z. A., & Brandenburg, V. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.10.002 · Cited by 21
Beddhu, S., Boucher, R. E., Sun, J., Balu, N., Chonchol, M., Navaneethan, S., Chertow, G. M., Townsend, R., Haley, W., Cheung, A. K., et al. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02260-x · Cited by 10
Metadata
- Authors
- Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1974-03-28
- Volume
- 290
- Issue
- 13
- Pages
- 697-701
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2323589684
- Cited by
- 1,776
- References
- 5
- FWCI
- 31.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.